CTOs on the Move

CitrusAd

www.citrusad.com

 
CitrusAd streamlines media sales and ad serving for more than half of the top 20 retailers in the world. Our Sponsored Product, Display Ad and Inventory Managent system is second to none
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Sitecore

Sitecore delivers a digital experience platform that empowers the world`s smartest brands to build lifelong relationships with their customers. A highly decorated industry leader, Sitecore is the only company bringing together content, commerce, and data into one connected platform that delivers millions of digital experiences every day. Leading companies including American Express, ASOS, Carnival Cruise Lines, Kimberly-Clark, L`Oréal and Volvo Cars rely on Sitecore to provide more engaging, personalized experiences for their customers. Learn more at Sitecore.com. Our employees are our foundation. Sitecore is built upon a diverse group of passionate, innovative, and collaborative individuals located across four continents and over 20 countries. The Sitecore values of Foster Collaboration, Push Boundaries, Take Ownership, Cultivate Community, and Customers First are what drive and unite us across the globe.

MK Decision

MK Decision partners with financial institutions to automate loan origination and online credit card issuance via our end-to-end platform.

Community Trust Corp

Community Trust Corp is a Suwanee, GA-based company in the Software and Internet sector.

Token

Token is a universal authenticator. Use Token as a simple and secure replacement for your passwords, house key, credit cards, car key, access badge and transit card.

Immunome

Immunome is a biotechnology company with a growing pipeline of cancer immunotherapies fueled by the human immune system. Our unique and powerful immunotherapy discovery engine leverages “most highly educated” immune systems from patients who have already learned how to fight off their disease. This proprietary technology platform enables the simultaneous discovery of novel antigens and the patient-derived, native antibodies that target those antigens. We then employ a battery of high-content screening technologies to identify specific and high-affinity antibodies that offer significant therapeutic potential to change the way we treat cancer.